Leadership
3VO team members each have 20+ years of medical device experience in both start up and corporate companies. Our team members have held executive, development and implementation roles from concept to >$300mil value developing novel therapies using minimally invasive procedures, catheter based systems and capital equipment. All of our team members specialize in Class II/III 510(K) and PMA medical devices with relevant experience in leadership, technical and commercial positions. The team was selected based on complementary expertise in industry best practices and a successful history of capitalization, product realization and commercialization


Ed Chinchoy Ph.D. is the CEO of 3VO.  Ed was most recently the Executive Vice President of VisCardia. Prior to that he held a variety of leadership and management positions at Medtronic and Abbott (St Jude Medical) in global upstream marketing, product planning and management positions. He has served as the champion of several significant novel PMA therapies and 510(k) procedures leading to over $1bil in new annual revenue, and led the multi-national commercialization of over 20 medical devices, platforms and novel therapies. Ed holds 24 patents with a doctorate in biomedical engineering from the University of Minnesota.

Jim Kelley is executive vice president for program management and research and development. Jim has 30+ years of broad, cross-functional Class II/III medical device industry experience including general management of global research and development, operations and manufacturing for therapy delivery systems and minimally invasive medical device portfolios for catheters, leads and navigation systems. Jim’s prior responsibilities includes overall business unit and product development leadership for diagnostic and therapeutic electrophysiology catheters at several large, mid sized and small medical device companies including Medtronic, St. Jude Medical and Ativa Medical. A graduate of the University of Minnesota, Jim holds over 30 patents and has brought over 60 products to market.

Therri Ruffin is vice president of commercialization and finance. Therri has over 30 years of medical device market development and commercialization experience including conversion of clinical practices from invasive surgical procedures to novel minimally invasive interventions. Therri's career has spanned multiple marketing leadership and management positions at NuVasive, St Jude Medical (Abbott) and Smith and Nephew focused on market development, brand management and global product launches. A graduate of the University of Memphis with a finance degree, she is also a certified public accountant.

Jay Snell is head of user experience, regulatory, and clinical systems engineering for 3VO. Jay has over 30 years of experience in upstream Class II/III medical device with roles in product design and development, clinical research, field engineering, and regulatory affairs.  His combination of in-house product engineering with extensive field clinical experience differentiates his expertise identifying and mitigating clinical and technical risks up to life-supporting and/or life-sustaining medical technologies. He has a notable record of supporting multiple first-in-human studies in the medical device industry in pivotal engineering and field roles including for the steerable RF ablation catheter, the implantable bipolar pacing lead, and the dual chamber implantable cardiac defibrillator. Jay has worked within a wide variety of organizational structures at St Jude Medical, Ventritex, BIOTRONIK, RS Medical, Siemens PaceSetter, and EP Systems and has managed the successful completion of 5 pivotal IDE trials for novel implantable and catheter products to approval. Jay is a graduate of Cal State Northridge who holds 9 patents and a US veteran with active duty served in Vietnam.



3rd Version of birthing from pharmacologic, to surgical, to minimally invasive